A mutation of the human IT15 gene is responsible for Huntington's disease (HD) and the causative factor in the major neuronal loss observed in the striatum. The growth factors basic fibroblast growth factor (FGF-2), nerve growth factor (NGF), and brain-derived neurotrophic factor (BDNF) improve survival and promote differentiation of striatal neurons, as well as exert a neuroprotective effect when such neurons are challenged with metabolic toxins or excitatory amino acids. Using Western blotting and striatal cell cultures, we found that FGF-2 increased the level of huntingtin in a dose-dependent fashion, whereas NGF decreased huntingtin expression. The neurotrophic factor-specific, dose-dependent effect on striatal levels of huntingtin may be relevant to understanding the normal role of IT15 and developing new therapies against the disease provoking mutated IT15.
AmbroseC. M.; DuyaoM. P.; BarnesG.; BatesG. P.; LinC. S.; SrinidhiJ.; BaxendaleS.; HummerichH.; LehrachH.; AltherrM.; WasmuthJ.; BucklerA.; ChurchD.; HousmanD.; BerksM.; MicklemG.; DurbinR.; DodgeA.; ReadA.; GusellaJ.; MacDonaldM. E.Structure and expression of the Huntington's disease gene: Evidence against simple inactivation due to an expanded CAG repeat.Somat. Cell Mol. Genet.20: 27–38; 1994.
2.
ChengB.; MattsonM. P.NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis.Neuron7: 1031–1041; 1991.
3.
ChengB.; MattsonM. P.NT–3 and BDNF protect CNS neurons against metabolic/excitotoxic insults.Brain Res.640: 56–67; 1994.
4.
DaviesS. W.; TurmaineM.; CozensB. A.; DiFigliaM.; SharpA. H.; RossC. A.; ScherzingerE.; WankerE. E.; MangiariniL.; BatesG.Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.Cell90: 537–548; 1997.
5.
EmerichD. F.; LindnerM. D.; WinnS. R.; ChenE.-Y.; FrydelB.; KordowerJ. H.Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease.J. Neurosci.16: 5168–5181; 1996.
6.
EmerichD. F.; WinnS. R.; HantrayeP. M.; PeschanskiM.; ChenE. Y.; ChuY.; McDermottP.; BaetgeE. E.; KordowerJ. H.Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.Nature386: 395–399; 1997.
7.
FreeseA.; FinklesteinS. P.; DiFigliaM.Basic fibroblast growth factor protects striatal neurons in vitro from NMDA-receptor mediated excitotoxicity.Brain Res.575: 351–355; 1992.
8.
FriedlanderR. M.; GagliardiniV.; HaraH.; FinkK. B.; LiW.; MacDonaldG.; FishmanM. C.; GreenbergA. H.; MoskowitzM.; YuanJ.Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury.J. Exp. Med.185: 933–940; 1997.
9.
FrimD. M.; ShortP.; RosenbergW. S.; SimpsonJ.; BreakefieldX. O.; IsacsonO.Local protective effects of nerve growth factor-secreting fibroblasts against excitotoxic lesions in the rat striatum.J. Neurosurg.78: 267–273; 1993.
10.
GalpernW. R.; MatthewsR. T.; BealM. F.; IsacsonO.NGF attenuates 3-nitrotyrosine formation in a 3-NP model of Huntington's disease.Neuroreport7: 2639–2642; 1996.
11.
HaqueN. S. K.; IsacsonO.Antisense gene therapy for neurodegenerative disease.Exp. Neurol.144: 139–146; 1997.
12.
HaraH.; FriedlanderR. M.; GagliardiniV.; AyataC.; FinkK.; HuangZ.; Shimizu-SasamataM.; YuanJ.; MoskowitzM. A.Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage.Proc. Natl. Acad. Sci. USA94: 2007–2012; 1997.
13.
KimM.; LeeH. S.; LaForetG.; McIntyreC.; MartinE. J.; ChangP.; KimT. W.; WilliamsM.; ReddyP. H.; TagleD.; BoyceF. M.; WonL.; HellerA.; AroninN.; DiFigliaM.Mutant huntingtin expression in clonal striatal cells: Dissociation of inclusion formation and neuronal survival by caspase inhibition.J. Neurosci.19: 964–973; 1999.
14.
KnuselB.; GaoH.; OkazakiT.; YoshidaT.; MoriN.; HeftiF.; KaplanD. R.Ligand-induced down-regulation of trk messenger RNA, protein and tyrosine phosphorylation in rat cortical neurons.Neuroscience78: 851–862; 1997.
15.
MangiariniL.; SathasivamK.; SellerM.; CozensB.; HarperA.; HetheringtonC.; LawtonM.; TrottierY.; LehrachH.; DaviesS.; BatesG. P.Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.Cell87: 493–506; 1996.
NakaoN.; BrundinP.; FunaK.; LindvallO.; OdinP.Trophic and protective actions of brain-derived neurotrophic factor on striatal DARPP-32-containing neurons in vitro.Dev. Brain Res.90: 92–101; 1995.
18.
NakaoN.; OdinP.; LindvallO.; BrundinP.Differential trophic effects of basic fibroblast growth factor, insulinlike growth factor-1, and neurotrophin-3 on striatal neurons in culture.Exp. Neurol.138: 144–157; 1996.
19.
PakzabanP.; DeaconT.; BurnsL.; IsacsonO.Increased proportion of AChE-rich zones and improved morphologic integration in host striatum of fetal grafts derived from the lateral but not the medial ganglionic eminence.Exp. Brain Res.97: 13–22; 1993.
20.
SchumacherJ. M.; ShortM. P.; HymanB. T.; BreakefieldX. O.; IsacsonO.Intracerebral implantation of nerve growth factor-producing fibroblasts protects striatum against neurotoxic levels of excitatory amino acids.Neuroscience45: 561–570; 1991.
21.
SharpA. H.; RossC. A.Neurobiology of Huntington's disease.Neurobiol. Dis.3: 3–15; 1996.
22.
TatterS. B.; GalpernW. R.; HoogeveenA. T.; IsacsonO.Effects of striatal excitotoxicity on huntingtin-like immunoreactivity.Neuroreport6: 1125–1129; 1995.
23.
The Huntington's Disease Collaborative Research Group.A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.Cell72: 971–983; 1993.
24.
VeneroJ. L.; KnuselB.; BeckK. D.; HeftiF.Expression of neurotrophin and trk receptor genes in adult rats with fimbria transections: Effect of intraventricular nerve growth factor and brain-derived neurotrophic factor administration.Neuroscience59: 797–815; 1994.
25.
WeissJ. H.; KohJ. Y.; BaimbridgeK.; ChoiD. W.Cortical neurons containing somatostatin- or parvalbumin-like immunoreactivity are atypically vulnerable to excitotoxic injury.Neurology40: 1288–1292; 1990.
26.
ZhouD.; DiFigliaM.Basic fibroblast growth factor enhances the growth of postnatal neostriatal GABAergic neurons in vitro.Exp. Neurol.122: 171–188; 1993.
